Is ZIMMER BIOMET HOLDINGS, INC. (ZBH) Halal?

NYSE Healthcare United States $17.6B
✗ NOT HALAL
Confidence: 90/100
ZIMMER BIOMET HOLDINGS, INC. (ZBH) is Not Halal under AAOIFI Standard 21. The company's debt ratio of 40.3% exceeds the 30% threshold, indicating excessive interest-bearing debt relative to market capitalization. ZIMMER BIOMET HOLDINGS, INC. operates in the Healthcare sector.

Shariah Screening — 5 Standards

Based on financial data from December 2025

Standard Debt Ratio Cash Ratio Receivables Income Status
AAOIFI 40.3%
/ 30%
3.2%
/ 30%
9.1%
/ 30%
2.83%
/ 5%
✗ NOT HALAL
DJIM 40.3%
/ 33%
3.2%
/ 33%
9.1%
/ 33%
2.83%
/ 5%
✗ NOT HALAL
MSCI 32.6%
/ 33%
2.6%
/ 33%
7.4%
/ 33%
2.83%
/ 5%
✓ HALAL
S&P 40.3%
/ 33%
3.2%
/ 33%
9.1%
/ 33%
2.83%
/ 5%
✗ NOT HALAL
FTSE 32.6%
/ 33%
2.6%
/ 33%
7.4%
/ 50%
2.83%
/ 5%
✓ HALAL

Financial Highlights

P/E Ratio
24.9
Forward: 9.9
EPS
$3.55
Dividend Yield
108.0%
Payout: 27.0%
P/B Ratio
1.4
EV/EBITDA
9.9
EV: $24.6B
Revenue
$8.2B
Growth: 10.9%
Beta
0.6
Low volatility
Current Ratio
2.0

Profitability

Gross Margin 69.7%
Operating Margin 14.0%
Net Margin 8.6%
Return on Equity (ROE) 5.6%
Return on Assets (ROA) 3.9%

Cash Flow & Balance Sheet

Operating Cash Flow$1.7B
Free Cash Flow$1.4B
Total Debt$7.5B
Debt-to-Equity62.0
Current Ratio2.0
Total Assets$23.1B

Price & Trading

Last Close$89.15
50-Day MA$91.85
200-Day MA$95.11
Avg Volume2.2M
Beta0.6
52-Week Range
$84.59
$114.44

About ZIMMER BIOMET HOLDINGS, INC. (ZBH)

CEO
Mr. Ivan Tornos
Employees
17,000
Sector
Healthcare
Industry
Medical Devices
Country
United States
Exchange
NYSE
Market Cap
$17.6B
Currency
USD

Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, upper extremities, and trauma and CMFT products; sports medicine products for the repair of soft tissue injuries, used in the knee and shoulder; and craniomaxillofacial and thoracic products comprising face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open-heart surgery, trauma, or for deformities of the chest. It offers technology and data, bone cement, and surgical products; and a suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, hospitals, healthcare institutions, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. It also offers ROSA Robot, which utilizes robotic technologies to assist a surgeon with implant positioning in total knee arthroplasty or partial knee arthroplasty; and the ZBEdge Platform connects robotic and digital technologies together to collect data before, during and after surgery, that can deliver insights to surgeons to assist in making informed decisions on patient care. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.

Related Halal Stocks in Healthcare

Frequently Asked Questions

Is ZIMMER BIOMET HOLDINGS, INC. (ZBH) halal to invest in?

Based on our screening using AAOIFI Standard 21 (the strictest methodology), ZIMMER BIOMET HOLDINGS, INC. is Not Halal. The company fails one or more screening criteria. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.

What is ZIMMER BIOMET HOLDINGS, INC.'s debt ratio?

ZIMMER BIOMET HOLDINGS, INC.'s debt ratio is 40.3% under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 32.6%.

What are ZIMMER BIOMET HOLDINGS, INC.'s key financial metrics?

ZIMMER BIOMET HOLDINGS, INC. has a market capitalization of $17.6B, trailing P/E ratio of 24.9, and revenue of $8.2B. The company maintains a gross margin of 69.7% and a net margin of 8.6%. Return on equity stands at 5.6%.

How often is the screening data updated?

Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.

Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.